This is an online event presented by Mintz. Sign in instructions will be sent prior to the presentation.
Overview (Program Summary)
A program hosted by:
ACC San DiegoThis 90-minute webinar will explore the processes, considerations, and other factors behind the incubation and launch of new companies by some of today’s leading venture capital firms. We’ll address the following key questions and topics:
- What are common sources of ideas for new companies and how do VC business models facilitate and measure the progress and de-risking of translational science?
- How do venture firms approach financing a new entity and how do they balance capital at risk and value capture with syndication and/or non-dilutive funding from partnerships?
- What are venture firms’ views on founder equity for inventors, for initial key team members, and for their own firms in their capacity as new company founders?
What are key steps to creating an ideal initial management team?
Speakers
Moderator: Lewis Geffen , Member / Co-chair, Life Sciences and Venture Capital & Emerging Companies Practices, Mintz Speakers: Nessan Bermingham, PhD, Serial entrepreneur and investor; currently President & CEO, Triplet Therapeutics,Executive Chairman, Korro Bio |